Log in

NYSE:BDX - Becton Dickinson and Stock Price, Forecast & News

$277.08
+0.21 (+0.08 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$275.30
Now: $277.08
$278.43
50-Day Range
$255.67
MA: $268.57
$277.30
52-Week Range
$221.47
Now: $277.08
$279.62
Volume1.17 million shs
Average Volume1.28 million shs
Market Capitalization$74.94 billion
P/E Ratio23.72
Dividend Yield1.14%
Beta1.07
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07588710
Phone201-847-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.29 billion
Cash Flow$20.86 per share
Book Value$78.08 per share

Profitability

Net Income$1.23 billion

Miscellaneous

Employees70,093
Market Cap$74.94 billion
Next Earnings Date2/6/2020 (Confirmed)
OptionableOptionable

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.


A Rare Upcoming Change to Bitcoin Could Yield Profits of 2,752% (Ad)


Free Report: In a few months the Bitcoin network will undergo a major change that will make it more scarce than ever before. Historically, this event has been correlated to a major price increase.

Becton Dickinson and (NYSE:BDX) Frequently Asked Questions

What is Becton Dickinson and's stock symbol?

Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and?

Becton Dickinson and declared a quarterly dividend on Monday, November 25th. Investors of record on Tuesday, December 10th will be paid a dividend of $0.79 per share on Tuesday, December 31st. This represents a $3.16 annualized dividend and a yield of 1.14%. The ex-dividend date of this dividend is Monday, December 9th. This is a boost from Becton Dickinson and's previous quarterly dividend of $0.77. View Becton Dickinson and's Dividend History.

How were Becton Dickinson and's earnings last quarter?

Becton Dickinson and Co (NYSE:BDX) posted its earnings results on Tuesday, November, 5th. The medical instruments supplier reported $3.31 EPS for the quarter, beating the Zacks' consensus estimate of $3.30 by $0.01. The medical instruments supplier earned $4.58 billion during the quarter, compared to the consensus estimate of $4.57 billion. Becton Dickinson and had a return on equity of 15.52% and a net margin of 6.84%. Becton Dickinson and's quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm posted $2.93 EPS. View Becton Dickinson and's Earnings History.

When is Becton Dickinson and's next earnings date?

Becton Dickinson and is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Becton Dickinson and.

How can I listen to Becton Dickinson and's earnings call?

Becton Dickinson and will be holding an earnings conference call on Thursday, February 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Becton Dickinson and issued on next quarter's earnings?

Becton Dickinson and updated its FY20 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $12.50-12.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.93. The company issued revenue guidance of $17.98-18.07 billion, compared to the consensus revenue estimate of $18.13 billion.

What price target have analysts set for BDX?

10 analysts have issued 1-year price targets for Becton Dickinson and's shares. Their forecasts range from $250.00 to $300.00. On average, they anticipate Becton Dickinson and's stock price to reach $277.70 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Price Targets for Becton Dickinson and.

What is the consensus analysts' recommendation for Becton Dickinson and?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton Dickinson and in the last year. There are currently 4 hold ratings, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Becton Dickinson and.

Has Becton Dickinson and been receiving favorable news coverage?

Media coverage about BDX stock has trended negative on Saturday, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Becton Dickinson and earned a daily sentiment score of -2.0 on InfoTrie's scale. They also gave headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Becton Dickinson and.

Are investors shorting Becton Dickinson and?

Becton Dickinson and saw a increase in short interest during the month of December. As of December 13th, there was short interest totalling 3,980,000 shares, an increase of 5.0% from the November 28th total of 3,790,000 shares. Based on an average daily trading volume, of 1,180,000 shares, the short-interest ratio is currently 3.4 days. Approximately 1.5% of the company's stock are sold short. View Becton Dickinson and's Current Options Chain.

Who are some of Becton Dickinson and's key competitors?

What other stocks do shareholders of Becton Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton Dickinson and investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), NVIDIA (NVDA), Home Depot (HD), Visa (V), Exxon Mobil (XOM), AbbVie (ABBV), Cardinal Health (CAH), Chevron (CVX) and Mcdonald's (MCD).

Who are Becton Dickinson and's key executives?

Becton Dickinson and's management team includes the folowing people:
  • Mr. Vincent A. Forlenza, Chairman & CEO (Age 66)
  • Mr. Thomas E. Polen Jr., Pres & COO (Age 46)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 62)
  • Mr. Samrat S. Khichi, Exec. VP & Gen. Counsel (Age 52)
  • Mr. Patrick K. Kaltenbach, Exec. VP & Pres of the Life Sciences Segment (Age 56)

Who are Becton Dickinson and's major shareholders?

Becton Dickinson and's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Boston Trust Walden Corp (0.17%), Douglass Winthrop Advisors LLC (0.12%), Cacti Asset Management LLC (0.08%), Hahn Capital Management LLC (0.05%), Gillespie Robinson & Grimm Inc. (0.05%) and Artemis Investment Management LLP (0.04%). Company insiders that own Becton Dickinson and stock include Alexandre Conroy, Betty D Larson, Catherine M Burzik, Charles R Bodner, Claire Fraser, David F Melcher, James C Lim, James W Borzi, John E Gallagher, Nabil Shabshab, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas E Polen Jr, Thomas J Spoerel, Timothy M Ring and Vincent A Forlenza. View Institutional Ownership Trends for Becton Dickinson and.

Which major investors are selling Becton Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including Rhenman & Partners Asset Management AB, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Artemis Investment Management LLP, Nisa Investment Advisors LLC, Cacti Asset Management LLC, Boston Trust Walden Corp, State of Alaska Department of Revenue and Hahn Capital Management LLC. Company insiders that have sold Becton Dickinson and company stock in the last year include Alexandre Conroy, Betty D Larson, Charles R Bodner, Claire Fraser, James C Lim, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas J Spoerel and Vincent A Forlenza. View Insider Buying and Selling for Becton Dickinson and.

Which major investors are buying Becton Dickinson and stock?

BDX stock was purchased by a variety of institutional investors in the last quarter, including Johanson Financial Advisors Inc., Commerzbank Aktiengesellschaft FI, GPM Growth Investors Inc., DNB Asset Management AS, Webster Bank N. A., Hemenway Trust Co LLC, Somerville Kurt F and UNIVEST FINANCIAL Corp. Company insiders that have bought Becton Dickinson and stock in the last two years include Catherine M Burzik and David F Melcher. View Insider Buying and Selling for Becton Dickinson and.

How do I buy shares of Becton Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Becton Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $277.08.

How big of a company is Becton Dickinson and?

Becton Dickinson and has a market capitalization of $74.94 billion and generates $17.29 billion in revenue each year. The medical instruments supplier earns $1.23 billion in net income (profit) each year or $11.68 on an earnings per share basis. Becton Dickinson and employs 70,093 workers across the globe.View Additional Information About Becton Dickinson and.

What is Becton Dickinson and's official website?

The official website for Becton Dickinson and is http://www.bd.com/.

How can I contact Becton Dickinson and?

Becton Dickinson and's mailing address is ONE BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.


MarketBeat Community Rating for Becton Dickinson and (NYSE BDX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  502 (Vote Outperform)
Underperform Votes:  582 (Vote Underperform)
Total Votes:  1,084
MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and and other stocks. Vote "Outperform" if you believe BDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Featured Article: Debt-To-Equity Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel